GA-ASI Awarded FMS Development Contract for MQ-9B PROTECTOR
General Atomics Aeronautical Systems, Inc. (GA-ASI) is pleased to announce the recent award of a $81M Foreign Military Sales contract by the US Air Force Life Cycle Management Center for the United Kingdom (UK) MQ-9B PROTECTOR unmanned aircraft system programme. This contract provides for integration and component level testing for UK specific enhancements to support the MQ-9B PROTECTOR programme. GA-ASI performed the first flight of the MQ-9B configuration less than two years ago, and the Remotely Piloted Aircraft (RPA) has continued to meet a series of key qualification milestones.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180408005029/en/
MQ-9B is the “Certifiable” (STANAG 4671) version of GA-ASI’s MQ-9 Predator® B product line. It can meet the stringent airworthiness certification requirements of various military and civil authorities, including the UK Military Airworthiness Authority (MAA) and the US FAA. (Photo: Business Wire)
MQ-9B is the “Certifiable” (STANAG 4671) version of GA-ASI’s MQ-9 Predator® B product line. Its development is the result of a five-year, company-funded effort to deliver a RPA that can meet the stringent airworthiness certification requirements of various military and civil authorities, including the UK Military Airworthiness Authority (MAA) and the US FAA. MQ-9B is the latest evolution of the multi-mission Predator B fleet. GA-ASI named its baseline MQ-9B SkyGuardian™, and the maritime surveillance variant, SeaGuardian.
“MQ-9B represents the next generation of RPA system capabilities,” said Linden Blue, CEO, GA-ASI. “It has demonstrated new airborne endurance records (>48 hours) and automatic takeoffs and landings under SATCOM-only control. MQ-9B will also have our currently operational MQ-9 detect and avoid system (with collision-avoidance radar), which will support MQ-9B operations in civil airspace.”
Other important MQ-9B milestones were achieved in 2017, including the first FAA-approved flight for a company-owned RPA through non-segregated airspace without a “chase aircraft,” when the RPA flew from Yuma, Arizona to Gray Butte, California in August 2017.
Upcoming aircraft qualification milestones include lightning protection tests, which are expected within the next 60 days. The aircraft system’s overall qualification schedule remains on track.
A weaponized variant of the system is being acquired by the Royal Air Force (RAF) under the UK’s MQ-9B PROTECTOR programme. The MQ-9B PROTECTOR will fly in excess of 40 hours with airspeeds up to 210 knots, reach altitudes of more than 40,000 feet, and carry 4750lbs (2159 kg) of external payload.
“The UK MOD and RAF are pleased with the progress of their MQ-9B PROTECTOR programme and work continues at pace on the certification aspects of this platform, ahead of achieving a full Military Type Certificate as the platform enters service. Recently-reported Protector procurement schedule adjustments reflect the UK government managing the transition between getting the most out of our current Reaper aircraft, which is helping us defeat Daesh in the Middle East, and moving to the cutting-edge Protector,” said Air Marshal Julian Young, Chief of Materiel (Air) at DE&S. “The Protector programme, which is based on GA-ASI’s SkyGuardian aircraft, is a key capability for the UK, and the MOD and GA-ASI have worked collaboratively to support programme changes, as well as continuing to meet growing interest in this unique capability.”
Hi-resolution photos of MQ-9B are available to qualified media outlets from the listed GA-ASI media contact.
General Atomics Aeronautical Systems, Inc. (GA-ASI), an affiliate of General Atomics, is a leading designer and manufacturer of proven, reliable Unmanned Aircraft Systems (UAS), radars, and electro-optic and related mission systems, including the Predator®, Reaper® and Gray Eagle UAS programs of record and the Lynx® Multi-mode Radar. Celebrating over 25 years of aviation innovation, GA-ASI provides long-endurance, multi-mission capable aircraft with integrated sensor and data link systems required to deliver persistent flight, enabling situational awareness and rapid strike. The company also produces a variety of ground control stations and sensor control/image analysis software, offers pilot training and support services, and develops meta-material antennas. For more information, visit www.ga-asi.com.
Predator, Reaper, and Lynx are registered trademarks and SkyGuardian is a trademark of General Atomics Aeronautical Systems, Inc.
General Atomics Aeronautical Systems, Inc.
+1 (858) 524-8108
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
PSE: APM Forum 2018 Focus on Digitalisation for the Process Industries20.4.2018 15:13 | Pressemelding
At the 2018 Advanced Process Modelling (APM) Forum this week, process industry organisations presented on digital design and operations applications ranging from accelerating development of the next generation of pharmaceuticals to realising millions of dollars per year in increased profit for large process plants. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180420005517/en/ Ben Weinstein, head of R&D Product and Process Systems Modeling at Procter & Gamble, delivers the keynote speech on how digital design techniques are used systematically to accelerate innovation in P&G. (Photo: Business Wire) Introducing the conference, Prof. Costas Pantelides, MD of conference host Process Systems Enterprise (PSE), described the current wave of digitalisation as the culmination of many years of advanced modelling and IT development. “This is a time of extraordinary opportunities for the process industries” he said. Keynote speaker Ma
Aperta Provides Electronic Funds Transfer (EFT) in Cayman Islands20.4.2018 14:01 | Pressemelding
Once again, the Aperta Active Clearing System (ACS) has delivered the mechanism for a country to implement a world-class electronic payment processing environment to maximize a national payments system’s efficiency, effectiveness, security and control. Aperta partnered with the Cayman Islands ACH Operator (Prism Services (Cayman) Ltd.) and local commercial banks to deliver a new Electronic Funds Transfer system. The old process of banks swapping files in a wide-variety of standards and settling bilaterally has been replaced with a common system and standards, employing international-standard secure file transfer protocol, allowing participants to monitor real time net settlement and collateral positions via a secure portal. The Cayman Islands Automated Clearinghouse (CIACH) links all six of the country’s banks and provides the central clearing and settlement mechanism for banks to exchange direct debit and direct credit transactions seamlessly across the country. It is functionally NAC
FII Tech Growth Invests in SECO20.4.2018 13:39 | Pressemelding
FII Tech Growth, a fund managed by Fondo Italiano d’Investimento SGR, announces today its second investment in SECO SpA, one of the European leaders in the embedded electronics market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180420005413/en/ (Photo: SECO) SECO, headquartered in Arezzo, Tuscany, with subsidiaries in the U.S.A., Germany and Taiwan, was founded in 1979 by entrepreneurs Daniele Conti and Luciano Secciani. The company designs and manufactures micro-computers and integrated systems for industrial applications. With more than 250 employees, SECO supports customers with a worldwide presence such as Cimbali, Esaote, Technogym and Vimar, and generated revenue in excess of Euro 50 million in 2017. The ability to offer innovative solutions by using cutting-edge technologies has allowed SECO to grow steadily over time. The company developed a network of collaborations with universities and research centres La Sapi
Schlumberger Announces First-Quarter 2018 Results20.4.2018 11:05 | Pressemelding
Schlumberger Limited (NYSE:SLB) today reported results for the first quarter of 2018. (Stated in millions, except per share amounts) Three Months Ended Change Mar. 31, 2018 Dec. 31, 2017 Mar. 31, 2017 Sequential Year-on-year Revenue $7,829 $8,179 $6,894 -4% 14% Pretax operating income $974 $1,155 $757 -16% 29% Pretax operating margin 12.4% 14.1% 11.0% -169 bps 145 bps Net income (loss) - GAAP basis $525 $(2,255) $279 n/m 88% Net income, excluding charges & credits* $525 $668 $347 -21% 51% Diluted EPS (loss per share) - GAAP basis $0.38 $(1.63) $0.20 n/m 90% Diluted EPS, excluding charges & credits* $0.38 $0.48 $0.25 -21% 52% *These are non-GAAP financial measures. See section below entitled "Charges & Credits" for details. n/m = not meaningful Schlumberger Chairman and CEO Paal Kibsgaard commented, “As forecast, our results in the first quarter of 2018 largely reflected transitory factors, with seasonal reductions in activity in the Northern Hemisphere and planned project startup costs
Biogen and Ionis Expand Strategic Collaboration to Develop Drug Candidates for a Broad Range of Neurological Diseases20.4.2018 10:30 | Pressemelding
Biogen (Nasdaq: BIIB) and Ionis Pharmaceuticals (Nasdaq: IONS) announced today they have expanded their strategic collaboration through a new ten-year collaboration agreement to develop novel antisense drug candidates for a broad range of neurological diseases. This collaboration capitalizes on Biogen’s expertise in neuroscience research and drug development and Ionis’ leadership in RNA targeted therapies with the goal of developing a broad pipeline of investigational therapies. It builds upon a productive collaboration that produced SPINRAZA, the first and only approved treatment for patients with spinal muscular atrophy. Today, April 20, 2018, Biogen and Ionis will host company conference calls and webcasts to discuss the new collaboration. Full webcast details can be found below. Under the terms of the collaboration, Biogen will pay Ionis $1 billion in cash, which will include $625 million to purchase 11,501,153 shares of Ionis common stock at a price of $54.34 per share, at an appr
Versum Materials Celebrates the Grand Opening of Its Research and Development Facility in Hometown, PA19.4.2018 20:37 | Pressemelding
Versum Materials, Inc. (NYSE: VSM), a leading materials supplier to the semiconductor industry, announced today the grand opening of its new research and development (R&D) facility at its semiconductor materials manufacturing site in Hometown, Pennsylvania. The ribbon-cutting ceremony took place April 10, 2018. Versum employees, members of the community, local government, customers and strategic partners attended the event. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180419006305/en/ Versum Materials ribbon-cutting ceremony at the company's new R&D facility in Hometown, PA. (Photo: Business Wire) The state-of-the-art R&D laboratory is dedicated to new materials used in the manufacture of semiconductors. Scientists in the facility will synthesize and purify new molecules down to parts per billion impurity levels and below using the latest technologies available in the industry. The researchers can assess the applications f